Vivendi: UBS reiterates its buy recommendation
(CercleFinance.com) - UBS reiterates its buy recommendation on the share with a target price of E15.
5 after providing more details on the proposed demerger of the businesses (Canal+, Havas and Louis Hachette Groupe) and the timetable for completion.
"Vivendi' management believe split assets into separate listed assets is feasible under satisfactory conditions, with a potential decision by the end of October 2024," the broker says.
This operation will only take place if it receives the approval of two-thirds of shareholder votes at the December general meeting. To date, no regulatory approvals have been identified as being necessary for this project to go ahead.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as decision-making aids for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.
5 after providing more details on the proposed demerger of the businesses (Canal+, Havas and Louis Hachette Groupe) and the timetable for completion.
"Vivendi' management believe split assets into separate listed assets is feasible under satisfactory conditions, with a potential decision by the end of October 2024," the broker says.
This operation will only take place if it receives the approval of two-thirds of shareholder votes at the December general meeting. To date, no regulatory approvals have been identified as being necessary for this project to go ahead.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as decision-making aids for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.